Ethically Sourced is moving to its own show entitled, “Curbside Ethics”. This is a noun as well as a verb.
In this episode, I discuss the revolutionary, new medication for Alzheimers Disease that was recently approved by the FDA, “aducanumab”. This medication brings into question multiple ethical issues. There are concerns about the research that developed the risk, benefits and side effect profiles. Additionally there is a question of resources as the medication is extremely expensive and may have a profound effect on Medicare funding.
Thank-you for following along during these exciting times. Stay tuned for your opportunity to subscribe to “Curbside Ethics.”